Elaine T. Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elaine T. Huang has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Amber Hoffman
Department of Cell, Developmental & Cancer Biology, Oregon Health and Science University, Portland, Oregon
32 shared publications - Aryn A. Alanizi
Department of Anatomy, University of California, San Francisco, San Francisco, California
32 shared publications - Briana Johnson
Department of Cell, Developmental & Cancer Biology, Oregon Health and Science University, Portland, Oregon
32 shared publications - Daniel S. Derrick
Department of Biomedical Engineering, Oregon Health and Science University, Portland, Oregon
32 shared publications - E. Shelley Hwang
Department of Surgery, Duke University Medical Center, Durham, NC
32 shared publications - Eric B. Berens
Department of Anatomy, University of California, San Francisco, San Francisco, California
32 shared publications
Latest Publications
- Open Access
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Figure S19 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
CD45 and CD69 are induced during 4T1 and MDA-MB-231 metastasis in mice
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S19 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
CD45 and CD69 are induced during 4T1 and MDA-MB-231 metastasis in mice
- Open Access
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Table S8 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S8 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
- Open Access
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Figure S16 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
CD45 and CD69 surface protein after paclitaxel treatment in a subset of breast cancer cell lines
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S16 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
CD45 and CD69 surface protein after paclitaxel treatment in a subset of breast cancer cell lines
- Open Access
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
Clusters of cells expressing mammary keratins and identification of mammary epithelial cells in reduction mammoplasty samples from the Pal and colleagues and Kumar and colleagues scRNA-seq datasets
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
Clusters of cells expressing mammary keratins and identification of mammary epithelial cells in reduction mammoplasty samples from the Pal and colleagues and Kumar and colleagues scRNA-seq datasets
- Open Access
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Figure S15 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
Continued experimental validation of neoplastic immune mimicry in breast cancer cell lines
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S15 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
Continued experimental validation of neoplastic immune mimicry in breast cancer cell lines
- Open Access
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Figure S20 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
Extended data for MDA-MB-231 CD69 CRISPR-activation experiments and the disruption of CD69 using CRISPR/Cas9
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S20 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
Extended data for MDA-MB-231 CD69 CRISPR-activation experiments and the disruption of CD69 using CRISPR/Cas9
- Open Access
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Table S6 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S6 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
- Open Access
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
Extended scRNA-seq analysis of mimicked cell states in the Pal and colleagues human breast tumor scRNA-seq dataset
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
Extended scRNA-seq analysis of mimicked cell states in the Pal and colleagues human breast tumor scRNA-seq dataset
- Open Access
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
Clusters of cells expressing mammary keratins and identification of the neoplastic compartment in the PANNTHR human breast tumor scRNA-seq dataset
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
Clusters of cells expressing mammary keratins and identification of the neoplastic compartment in the PANNTHR human breast tumor scRNA-seq dataset
- Open Access
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Figure S14 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
Histopathologic epithelial CD69 in human breast tumors stratified by clinical parameters
- 2 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S14 from Neoplastic Immune Mimicry Potentiates Breast Tumor Progression
Histopathologic epithelial CD69 in human breast tumors stratified by clinical parameters